The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
Official Title: An Open-Label, Multicenter, Long-Term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies
Study ID: NCT04164199
Brief Summary: This is an open-label, multicenter, extension study to evaluate the long-term safety and efficacy of BeiGene investigational drugs in participants with advanced malignancies who participated in a prior BeiGene-sponsored clinical study (parent study).
Detailed Description: For the purposes of this study, "study treatment" will refer to all investigational agents. A parent study is defined as the original BeiGene-sponsored clinical trial in which the participant was initially enrolled and received BeiGene investigational drugs (with or without other treatments).
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
The Second Hospital of Anhui Medical University, Hefei, Anhui, China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Beijing Cancer Hospital, Beijing, Beijing, China
Chongqing Cancer Hospital, Chongqing, Chongqing, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou, Guangdong, China
Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, China
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou, Guangdong, China
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
The Fifth Affiliated Hospital Sun Yat Sen University, Zhuhai, Guangdong, China
The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
Hainan Cancer Hospital, Haikou, Hainan, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Henan Cancer Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
Hubei Cancer Hospital, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
The First Peoples Hospital of Changzhou, Changzhou, Jiangsu, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi, China
Jilin Cancer Hospital, Changchun, Jilin, China
The First Hospital of Jilin University, Changchun, Jilin, China
First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
The First Affiliated Hospital of Xian Jiaotong University, Xian, Shaanxi, China
Shandong Cancer Hospital, Jinan, Shandong, China
Weifang Peoples Hospital, Weifang, Shandong, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Shanghai Chest Hospital, Shanghai, Shanghai, China
Affiliated Zhongshan Hospital of Fudan University, Shanghai, Shanghai, China
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
West China Second University Hospital, Chengdu, Sichuan, China
Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, China
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
Zhejiang University College of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, China
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Seoul National University Bundang Hospital, Seongnamsi, Gyeonggido, Korea, Republic of
Chiayi Chang Gung Memorial Hospital, Chiayi, , Taiwan
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, , Taiwan
Taichung Veterans General Hospital Gastroenterology, Taichung City, , Taiwan
China Medical University Hospital, Taichung, , Taiwan
National Cheng Kung University Hospital, Tainan, , Taiwan
Chi Mei Medical Center, Tainan, , Taiwan
Linkou Chang Gung Memorial Hospital, Taoyuan, , Taiwan
Acibadem Adana Hospital, Adana, , Turkey
Bakirkoy Sadi Konuk Eah, stanbulBakrkoy, , Turkey
Namik Kemal University, Tekirdag, , Turkey
Name: Study Director
Affiliation: BeiGene
Role: STUDY_DIRECTOR